drugset / Trial / NCT05390021
PET/MRI in Endometrial Cancer
Withdrawn
Massachusetts General Hospital
NaSingle-groupOpen-labelDiagnostic
Summary
This study is investigating if positron emission tomography (PET)/Magnetic resonance imaging (MRI) is more effective than the currently used imaging modalities (computed tomography \[CT\], or PET/CT) for high-risk endometrial cancer. The name of the intervention involved in this study is: Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)
Timeline
- Start
- 2024-03-30
- Primary completion
- 2025-02-01
- Completion
- 2026-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | 18F-FDG | Diagnostic / imaging agent | — | — |